STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

FibroGen (NASDAQ: FGEN) has announced its participation in the upcoming 24th Annual Needham Virtual Healthcare Conference, scheduled for April 7-10, 2025. The company's management team will be conducting one-on-one meetings with investors on Wednesday, April 9th, 2025. Interested investors are advised to reach out to their Needham representatives to schedule meetings.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025.

FibroGen’s management team will be available for one-on-one meetings on Wednesday, April 9th. Interested investors should contact their representative at Needham.

About FibroGen

FibroGen, Inc. is a biopharmaceutical company focused on development of novel therapies at the frontiers of cancer biology and anemia. Roxadustat (爱瑞卓®, EVRENZO™) is currently approved in China, Europe, Japan, and numerous other countries for the treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis. The Company continues to evaluate a development plan for roxadustat in anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) in the U.S. FG-3246 (also known as FOR46), a first-in-class antibody-drug conjugate (ADC) targeting CD46 is in development for the treatment of metastatic castration-resistant prostate cancer. This program also includes the development of FG-3180, an associated CD46-targeted PET biomarker. For more information, please visit www.fibrogen.com

For Investor Inquiries:
David DeLucia, CFA
Senior Vice President and Chief Financial Officer
ir@fibrogen.com


FAQ

When is FibroGen (FGEN) participating in the Needham Healthcare Conference 2025?

FibroGen will participate in the conference from April 7-10, 2025, with one-on-one meetings scheduled for April 9th, 2025.

How can investors meet with FGEN management at the Needham Healthcare Conference?

Interested investors should contact their Needham representative to schedule one-on-one meetings with FibroGen management.

What type of meetings will FGEN hold at the 2025 Needham Healthcare Conference?

FibroGen will hold one-on-one meetings with investors on Wednesday, April 9th, 2025.

Is the 2025 Needham Healthcare Conference where FGEN is participating virtual or in-person?

The 24th Annual Needham Healthcare Conference is a virtual event.
Fibrogen Inc

NASDAQ:FGEN

FGEN Rankings

FGEN Latest News

FGEN Latest SEC Filings

FGEN Stock Data

34.63M
3.98M
1.57%
26.51%
3.13%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN FRANCISCO